Cutler Group LP Albireo Pharma, Inc. Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$16.32 - $26.37 $1,632 - $2,637	100 New	100 $1,000
Q4 2021 Jan 18, 2022	SELL	$21.19 - $31.29 $2,119 - $3,129	-100 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$27.36 - $35.98 $2,736 - $3,597	100 New	100 $3,000
Q4 2020 Jan 21, 2021	SELL	$31.56 - $42.16 $93,259 - $124,582	-2,955 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$23.19 - $41.61 $68,526 - $122,957	2,955 New	2,955 $98,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.